128 related articles for article (PubMed ID: 8200988)
1. In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.
Parlevliet KJ; ten Berge IJ; Yong SL; Surachno J; Wilmink JM; Schellekens PT
J Clin Invest; 1994 Jun; 93(6):2519-25. PubMed ID: 8200988
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
3. Biphasic granulocytopenia after administration of the first dose of OKT3.
Bemelman FJ; Buysmann S; Yong SL; van Diepen FN; Schellekens PT; ten Berge RJ
J Lab Clin Med; 1995 Dec; 126(6):571-9. PubMed ID: 7490516
[TBL] [Abstract][Full Text] [Related]
4. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
Ceuppens JL; Bloemmen FJ; Van Wauwe JP
J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
[TBL] [Abstract][Full Text] [Related]
5. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.
Parlevliet KJ; Chamuleau ME; Yong SL; Raasveld MH; ten Berge IJ; Schellekens PT
Clin Exp Immunol; 1995 Feb; 99(2):155-9. PubMed ID: 7851005
[TBL] [Abstract][Full Text] [Related]
7. Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines.
Abbs IC; Clark M; Waldmann H; Chatenoud L; Koffman CG; Sacks SH
Ther Immunol; 1994 Dec; 1(6):325-31. PubMed ID: 7584508
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies.
van Seventer GA; Kuijpers KC; van Lier RA; de Groot ER; Aarden LA; Melief CJ
J Immunol; 1987 Oct; 139(8):2545-50. PubMed ID: 3498763
[TBL] [Abstract][Full Text] [Related]
9. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
Cole MS; Anasetti C; Tso JY
J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
[TBL] [Abstract][Full Text] [Related]
10. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.
Bolt S; Routledge E; Lloyd I; Chatenoud L; Pope H; Gorman SD; Clark M; Waldmann H
Eur J Immunol; 1993 Feb; 23(2):403-11. PubMed ID: 8436176
[TBL] [Abstract][Full Text] [Related]
11. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
[TBL] [Abstract][Full Text] [Related]
12. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
Sawchuk SS; Gates R; Hirsch R
Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
Boot JH; Geerts ME; Aarden LA
J Immunol; 1989 Feb; 142(4):1217-23. PubMed ID: 2492577
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.
Le Gall F; Reusch U; Moldenhauer G; Little M; Kipriyanov SM
J Immunol Methods; 2004 Feb; 285(1):111-27. PubMed ID: 14871540
[TBL] [Abstract][Full Text] [Related]
15. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of IgA anti-CD3 isotype switch variant in vivo.
ten Berge IJ; Parlevliet KJ; Yong SL; Surachno J; Wilmink JM; Schellekens PT
Transplant Proc; 1994 Dec; 26(6):3150. PubMed ID: 7998098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
